U.S. Banks Stock News

NasdaqGS:UBFO
NasdaqGS:UBFOBanks

United Security Bancshares (UBFO) Margin Decline Tests Bullish Narratives After FY 2025 Results

United Security Bancshares (UBFO) has just wrapped up FY 2025 with fourth quarter revenue of US$13.1 million and basic EPS of US$0.20, alongside full year trailing revenue of US$48.3 million and EPS of US$0.71. Over the past few reported periods, revenue has ranged from US$10.7 million in Q4 2024 to US$13.1 million in Q4 2025, while quarterly EPS has moved between US$0.13 and US$0.23. This sets a clear backdrop for how the FY 2025 results line up against FY 2024. With a trailing net profit...
NasdaqGS:BANF
NasdaqGS:BANFBanks

BancFirst (BANF) Net Interest Margin Near 3.8% Reinforces Bullish Profitability Narratives

BancFirst (BANF) has rounded out FY 2025 with Q4 revenue of US$182.7 million and basic EPS of US$1.78, while trailing twelve month revenue came in at US$685.0 million with EPS of US$7.22. The bank has seen revenue move from US$622.4 million and EPS of US$6.55 on a trailing basis a year earlier to the latest US$685.0 million and US$7.22 respectively, giving investors a clear sense of how the top line and EPS have tracked over the past year. With trailing net income of US$240.6 million and a...
NasdaqGS:JBHT
NasdaqGS:JBHTTransportation

Is J.B. Hunt (JBHT) Fairly Priced After Strong Five Year Share Price Performance

Wondering if J.B. Hunt Transport Services at around US$206 per share is giving you good value or asking too much? This article is designed to break that down in plain terms. The stock recently closed at US$206.75, with returns of 1.2% over 7 days, 4.3% over 30 days, 5.1% year to date, 23.1% over 1 year, 11.2% over 3 years, and 60.8% over 5 years. These figures may have some investors thinking about both growth potential and changes in risk. Recent attention on J.B. Hunt has been driven by...
NasdaqCM:CWBC
NasdaqCM:CWBCBanks

Community West Bancshares (CWBC) Margin Surge Challenges Long Term Earnings Decline Narrative

Community West Bancshares (CWBC) has wrapped up FY 2025 with fourth quarter revenue of US$37.8 million and basic EPS of US$0.59, while trailing twelve month revenue came in at US$142.9 million with EPS of US$2.01. Over the past year, the company has seen revenue move from US$105.7 million to US$142.9 million on a trailing basis, with net income shifting from US$7.7 million to US$38.2 million. This sets the stage for investors to focus on how these earnings feed into margin resilience and the...
NYSE:PJT
NYSE:PJTCapital Markets

Is It Too Late To Consider PJT Partners (PJT) After Its Strong Multi‑Year Rally?

If you are wondering whether PJT Partners at around US$181.61 is still good value after a strong run in recent years, you are not alone. The stock has had a mixed short term patch, with a 3.5% decline over the last 7 days, a 5.9% return over 30 days, 7.1% year to date, 11.1% over 1 year and a very large gain over 3 and 5 years. Recent news flow around PJT Partners has focused on its role as an independent advisory firm and its position in high profile restructuring and M&A assignments. This...
NasdaqGS:MLKN
NasdaqGS:MLKNCommercial Services

A Look At MillerKnoll (MLKN) Valuation After Fortune World’s Most Admired Companies 2026 Recognition

MillerKnoll (MLKN) recently drew fresh attention after being added to the Fortune World’s Most Admired Companies 2026 list, highlighting how the post merger furniture group is being viewed by global corporate peers. See our latest analysis for MillerKnoll. The recognition comes as MillerKnoll’s share price, last closing at US$19.59, shows a 30-day share price return of 8.23% and a 90-day share price return of 12.26%, even though the 1-year total shareholder return is a 9.33% decline. Recent...
NasdaqGS:SYNA
NasdaqGS:SYNASemiconductor

Is Synaptics (SYNA) Fairly Priced After Recent Share Price Rebound?

If you are wondering whether Synaptics shares are offering fair value right now, it helps to look past the headlines and focus on what the numbers are actually saying. The stock last closed at US$85.60, with returns of 15.9% over 30 days and 13.0% year to date, although the 7 day return of a 6.0% decline and a 31.8% decline over three years show a mixed picture for longer term holders. Over the past year, Synaptics shares have returned 2.7%, while the 5 year return stands at a 13.7% decline...
NasdaqCM:BHRB
NasdaqCM:BHRBBanks

Burke & Herbert Financial Services (BHRB) Net Margin Surge Tests Bullish Narratives

Burke & Herbert Financial Services (BHRB) has capped FY 2025 with fourth quarter revenue of US$86.4 million and EPS of US$2.00, against a trailing twelve month tally of US$340.5 million in revenue and EPS of US$7.72. The company has seen revenue move from US$233.0 million and EPS of about US$2.83 on a trailing basis a year earlier to US$340.5 million and EPS of US$7.72, which helps explain why trailing net income is now US$116.4 million. With net margin reported at 34.2% for the latest twelve...
OTCPK:UBOH
OTCPK:UBOHBanks

United Bancshares (OTCPK:UBOH) Net Interest Margin Improvement Tests Bearish Profitability Narratives

United Bancshares (UBOH) has rounded out FY 2025 with fourth quarter total revenue of US$12.6 million and basic EPS of US$1.04, alongside trailing twelve month revenue of US$47.0 million and EPS of US$4.04 that cap a year of stronger profitability. The company has seen total revenue move from US$41.8 million and EPS of US$3.06 on a trailing basis at the end of 2024 to US$47.0 million and US$4.04 respectively, setting up this latest report as a key reference point for how investors judge the...
NasdaqGS:SLM
NasdaqGS:SLMConsumer Finance

SLM (SLM) Net Margin Expansion Challenges Bearish Profitability Narratives In FY 2025 Results

SLM (SLM) closed out FY 2025 with Q4 revenue of US$472.9 million and basic EPS of US$1.14, while trailing 12 month EPS sat at US$3.52 on revenue of about US$1.7 billion. The company has seen quarterly revenue move from US$281.8 million and EPS of US$0.51 in Q4 FY 2024 to US$472.9 million and EPS of US$1.14 in Q4 FY 2025, alongside trailing 12 month EPS shifting between US$2.73 and US$3.52 over the same window. For investors, the combination of higher trailing margins and these headline...
NYSE:SSB
NYSE:SSBBanks

SouthState Bank (SSB) Cost Efficiency Gains Challenge Cautious Narratives On Profit Sustainability

SouthState Bank (SSB) has wrapped up FY 2025 with fourth quarter revenue of US$680.3 million and basic EPS of US$2.48, while trailing twelve month revenue came in at about US$2.6 billion and EPS at US$7.90. Over the past year, the bank has seen revenue move from US$1.70 billion on a trailing basis in Q4 2024 to roughly US$2.6 billion by Q4 2025, with trailing EPS rising from US$7.01 to US$7.90 across the same period. This provides a backdrop for investors to weigh that earnings profile...
NYSE:ORI
NYSE:ORIInsurance

Old Republic International (ORI) Combined Ratio Of 94.7% Challenges Earnings Decline Narrative

Old Republic International (ORI) closed out FY 2025 with fourth quarter revenue of US$2.4b, basic EPS of US$0.84 and net income of US$206.3m. The trailing twelve months show revenue of US$9.1b and EPS of US$3.82. Over the past year, revenue has moved from US$8.2b in the trailing period to Q4 2024 to US$9.1b in the latest trailing period, with EPS over those same trailing windows shifting from US$3.30 to US$3.82. For investors, the headline story is that Old Republic paired this top line and...
NasdaqGS:ALRM
NasdaqGS:ALRMSoftware

Is Sluggish Billings Growth And Modest Revenue Expansion Altering The Investment Case For Alarm.com (ALRM)?

In recent months, Alarm.com Holdings reported weak billings growth and signaled only modest revenue expansion, raising questions about customer acquisition momentum and demand trends. Although the company has improved operating margins and profitability, these gains have not fully eased concerns about the resilience of its growth profile. With recent returns under pressure, we’ll explore how Alarm.com’s sluggish billings growth shapes its investment narrative and future prospects. This...
NasdaqCM:PKBK
NasdaqCM:PKBKBanks

Parke Bancorp (PKBK) Net Margin Near 49% Reinforces Bullish Profitability Narratives

Parke Bancorp (PKBK) has just wrapped up FY 2025 with fourth quarter total revenue of US$22.2 million and basic EPS of US$0.95, capped by trailing twelve month revenue of US$77.4 million and EPS of US$3.20. Over recent periods the company has seen quarterly revenue move from US$16.6 million in Q4 2024 to US$22.2 million in Q4 2025, while basic EPS shifted from US$0.62 to US$0.95. This sets up a story where stronger recent profitability sits against a longer history of earnings pressure. See...
NYSE:CVI
NYSE:CVIOil and Gas

Is CVR Energy (CVI) Attractively Priced After Mixed Returns And Conflicting Valuation Signals?

If you are wondering whether CVR Energy at around US$24.54 is offering good value or asking too much, you are exactly who this breakdown is for. The stock has returned 5.3% over the last 7 days, while the 1 year return sits at 18.6%, alongside a 6.9% decline over 30 days and a 2.6% decline year to date. These shifts can change how investors think about both growth potential and risk. Recent coverage of CVR Energy has focused on its role in the energy sector and how investor expectations are...
NYSE:CTRE
NYSE:CTREHealth Care REITs

How Analyst Upgrades and Rising Earnings Estimates Will Impact CareTrust REIT (CTRE) Investors

Earlier this week, CareTrust REIT received a series of upbeat analyst actions, including an upgrade to a Zacks Rank #2 (Buy) and new coverage from Citizens with a Market Outperform rating, reflecting improving earnings estimates and a favorable outlook. What stands out is the broad consistency of broker opinions, with multiple firms reaffirming positive views that collectively signal strengthening confidence in CareTrust REIT’s business trajectory. With these analyst upgrades highlighting...
NYSE:USPH
NYSE:USPHHealthcare

U S Physical Therapy Faces Rising Competition And Capital Strain

U.S. Physical Therapy (NYSE:USPH) is seeing rising competition that is weighing on profitability and returns on capital. Recent analysis points to shrinking returns on capital and higher capital intensity across its clinic network. These trends suggest the company is needing to commit more capital to sustain its position in the outpatient physical therapy market. For investors tracking NYSE:USPH, the share price sits at $85.7, with the stock up 6.8% over the past 30 days and 8.6% year to...
NasdaqGS:EWBC
NasdaqGS:EWBCBanks

East West Bancorp (EWBC) Net Interest Margin Holds At 3.41% Reinforcing Bullish Profitability Narratives

East West Bancorp (EWBC) has wrapped up FY 2025 with fourth quarter revenue of US$711.1 million and basic EPS of US$2.58, alongside net income of US$356.3 million, putting fresh numbers behind the story at a share price of US$111.35. Over the past year, revenue on a trailing twelve month basis has moved from US$2.39 billion in Q4 2024 to US$2.70 billion in Q4 2025. Over the same period, trailing EPS has gone from US$8.39 to US$9.58, giving investors a fuller picture of earnings power through...
NasdaqCM:AMPL
NasdaqCM:AMPLSoftware

Is Amplitude (AMPL) Priced Attractive After Recent Share Price Weakness?

If you are wondering whether Amplitude’s current share price really reflects what the business is worth, you are not alone. This article is built to unpack exactly that question in a clear, practical way. The stock closed at US$10.25, with a 3% gain over the last 7 days, but it is still showing a 14.2% decline over 30 days and a 9.9% decline over 1 year, with a 30.7% decline over 3 years and a 6.2% decline year to date. Recent news flow around Amplitude has focused on its position in product...
NasdaqGM:GPCR
NasdaqGM:GPCRPharmaceuticals

Genentech Licensing Deal and Guggenheim Reaffirmation Could Be A Game Changer For Structure Therapeutics (GPCR)

Earlier in January 2026, Guggenheim reaffirmed its positive view on Structure Therapeutics, pointing to increased confidence in its oral obesity drug aleniglipron and progress on the early-stage candidate ACCG-2671. Guggenheim also highlighted Structure Therapeutics’ licensing deal with Genentech, which includes a US$100,000,000 upfront payment and potential royalties, underscoring external validation of its pipeline. Next, we’ll examine how Guggenheim’s confidence in aleniglipron’s...
NYSE:CRI
NYSE:CRILuxury

Assessing Carter’s (CRI) Valuation After A Recent Share Price Pullback And Mixed Return Profile

Short term move in context Carter's (CRI) has pulled back around 5.6% over the past day, even though the stock has shown a gain over the past month and the past 3 months. This has prompted some investors to reassess the recent move. See our latest analysis for Carter's. At a share price of $35.66, Carter's recent 5.6% one day pullback comes after a 30 day share price return of 12.46% and a year to date share price return of 7.41%. The 1 year total shareholder return of 31.08% and 5 year total...
NYSE:PRKS
NYSE:PRKSHospitality

Is It Time To Reassess United Parks & Resorts (PRKS) After Recent Share Price Weakness?

Wondering whether United Parks & Resorts at around US$37.49 is a bargain or a value trap right now? This article walks through what the current price might be telling you about the stock. The share price is up 5.3% over the last month and 3.5% year to date, but that sits against a 27.6% decline over the last year and a 40.2% decline over three years, which may have shifted how investors see both risk and potential reward. Recent coverage around United Parks & Resorts has highlighted the...
NasdaqCM:NKSH
NasdaqCM:NKSHBanks

National Bankshares (NKSH) Margin Improvement Challenges Longstanding Bearish Earnings Narrative

National Bankshares (NKSH) just wrapped up FY 2025 with fourth quarter total revenue of US$15.9 million and basic EPS of US$0.92, alongside net income of US$5.9 million. Trailing twelve month figures show revenue of US$55.6 million and EPS of US$2.49. Over the last few quarters, revenue has gone from US$12.3 million in Q4 2024 to US$15.9 million in Q4 2025, with basic EPS shifting from US$0.48 to US$0.92 across the same period. Trailing EPS moved from US$1.24 to US$2.49 as net profit margin...
NasdaqGM:ISTR
NasdaqGM:ISTRBanks

Investar Holding (ISTR) Margin Expansion Reinforces Bullish Profitability Narratives

Investar Holding (ISTR) has wrapped up FY 2025 with fourth quarter revenue of US$23.5 million and EPS of US$0.55, set against trailing twelve month revenue of US$93.6 million and EPS of US$2.22 that point to a solidly profitable year. The company has seen revenue move from US$86.3 million and EPS of US$2.06 on a trailing basis at the end of Q4 2024 to US$93.6 million and EPS of US$2.22 by Q4 2025, with net profit margin over the last year at 24.5% compared to 23.5% previously. With earnings...